Grafa News and Videos — Page 24

Moderna (NASDAQ:MRNA) shares climbed 2.2% to $193.01 premarket after Nasdaq said the vaccine maker will replace Warner Bros. Discovery (NASDAQ:WBD) in the Nasdaq-100 Index on October 9.

Brent crude fell 0.7% to $101.61 a barrel on Friday while West Texas Intermediate dropped 0.9% to $92.02 as traders weighed improving Middle Eastern supply against geopolitical risks.

South Korea’s virtual asset market saw trading volume fall 44% in the first half of 2026.

Venture Global (NYSE:VG) signed a 20-year sales and purchase agreement with ConocoPhillips (NYSE:COP) to supply 1.0 million tonnes of LNG annually beginning in 2030.

CareTrust REIT (NYSE:CTRE) agreed to acquire 45 U.K. care homes from LNT for about £1.1 billion, including 24 properties acquired for approximately £576 million in the first closing.

Cullinan Therapeutics (NASDAQ:CGEM) initiated an FDA New Drug Application for first-line zipalertinib plus chemotherapy after REZILIENT3 showed a 6.0-month median progression-free survival improvement.

South Korea’s Financial Services Commission has proposed rules for tokenised securities ahead of a February 2027 rollout.

Manulife (NYSE:MFC) completed its previously announced long-term care reinsurance transaction with Munich American Reassurance Company, covering a policy block with C$3.2 billion of reserves.

Ultragenyx (NASDAQ:RARE) announced that the European Medicines Agency validated its marketing authorisation application for investigational gene therapy rebisufligene etisparvovec to treat Sanfilippo syndrome Type A.

Summit Therapeutics (NASDAQ:SMMT) announced a clinical trial collaboration with AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo to evaluate ivonescimab with Datroway in multiple solid tumor settings, including breast and lung cancer.